Candel Therapeutics, Inc. ($CADL)
Filing Information
| Accession Number | 0001873905-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 11, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
530,245
Total Value
$3,354,533.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 10, 2026 | Exercise/Conversion | 125,000 | $1.55 | $193,750.00 | 393,566 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 10, 2026 | Sale | 220,866 | $11.50 | $2,539,892.74 | 172,700 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 11, 2026 | Sale | 59,379 | $10.46 | $620,890.58 | 113,321 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 10, 2026 | Exercise/Conversion | 125,000 | $0.00 | $0.00 | 1,638,968 | Direct | โ | View Details |